Tiletamine+Zolazepam

15 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

2670.0%

Death Rate

Active Ingredients

Tiletamine+Zolazepam

Administration Routes

UnknownParenteralIntravenousOtherIntramuscular

Species Affected

Cat 14

Dog 1

Most Affected Breeds

Domestic Shorthair 8

Cat (unknown) 3

Crossbred Feline/cat 1

Poodle (unspecified) 1

Domestic Mediumhair 1

Siamese 1

Most Reported Reactions

Not eating 4

Hyperactivity 4

Dysphoria 4

Death by euthanasia 2

Lethargy (see also Central nervous system depression in 'Neurological') 2

Death 2

Elevated temperature 2

Hypotension 2

Lack of efficacy - NOS 1

Recovery prolonged 1

Incorrect route of drug administration 1

Vomiting 1

Outcome Breakdown

Outcome Unknown

5 (33.3%)

Recovered/Normal

5 (33.3%)

Euthanized

2 (13.3%)

Died

2 (13.3%)

Ongoing

1 (6.7%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.